EKO International Inc (EKNL)

[Arbel]

EKNL – iMD partnership key access to thousands of Physicians, Centers, and Providers

EKNL just established itself with a leading technology innovator, iMD Health Canada (http://www.imdhealth.ca) - award winner provider of services that help Physicians, Patients, Pharmaceuticals and healthcare providers navigate the complexity of the healthcare literacy system.

This provides HUGE exposure to EKNL, Neurovasc, and their FDA approved FREMS Technology to treat Diabetic patients with Peripheral Nuropathy – a step to significantly increase sales and bottom line $$s

Article except: ”EKNL IS NOW PART OF AN ELITE CLUB OF MEDICAL PROFESSIONALS LIKE PFIZER, MERCK, AND ABBOTT WITH DIRECT ACCESS TO THOUSANDS OF PHYSICIAN, DIABETES EDUCATION CENTERS AND HEALTH CARE PROVIDERS FOR DIABETICS ACROSS CANADA.

EKO INITIATES UPLISTING TO HIGHER STOCK EXCHANGE WITH AUTHORIZED SHARE REDUCTION AND IDENTIFIES SHARE BUY-BACK PROGRAM.”

We are also on HIGH NEWS ALERT for additional updates to be unleashed by the company which if history is any indication, these updates will be HUGE and definitely trigger a breakout to record levels.

Smart investors were definitely adding to their positions for mega gains, we definitely took the advantage and we will be front and center again next week.

We stand 100% behind the potential here for xtreme gains and with all our CORE plays. We are also committed to continue to profile EKNL all month and well into December – no doubt we will see our $2 near term target reached and a 500%+ gain potential!